Antimicrobial and anticoagulant activities of N-chlorotaurine, N,N-dichloro-2,2-dimethyltaurine, and N-monochloro-2,2-dimethyltaurine in human blood

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 1979-1984

  Martini, C ^a   Hammerer Lercher, A ^b   Zuck, M ^c   Jekle, A ^c   Debabov, D ^c   Anderson, M ^c   Nagl, M ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c NovaBay Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; FIBRINOGEN; HEPARIN; N CHLOROTAURINE; N MONOCHLORO 2,2 DIMETHYLTAURINE; N,N DICHLORO 2,2 DIMETHYLTAURINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTICOAGULATION; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CATHETER INFECTION; CATHETER OCCLUSION; CONTROLLED STUDY; DOSE RESPONSE; ESCHERICHIA COLI; HUMAN; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PILOT STUDY; PRIORITY JOURNAL; PROTHROMBIN TIME; QUANTITATIVE ANALYSIS; THROMBIN TIME;

ANTI-BACTERIAL AGENTS; ANTICOAGULANTS; ANTIFUNGAL AGENTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BUFFERS; CANDIDA ALBICANS; ESCHERICHIA COLI; HEPARIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; SOLUTIONS; TAURINE; THROMBIN;

EID: 84858692201     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05685-11     Document Type: Article

References (28)

1. Casey AL, Elliott TS. 2010. Prevention of central venous catheter-related infection: update. Br. J. Nurs. 19:78-87.
2. Casey AL, Leonard AM, Peter N, Tom SE. 2008. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet 8:763-776.
3. Chittick P, Sherertz RJ. 2010. Recognition and prevention of nosocomial vascular device and related bloodstream infections in the intensive care unit. Crit. Care Med. 38:S363-S372.
4. Darouiche, D, et al. 2011. NVC-422. Drugs Future 36:651- 656.
5. del Pozo JL. 2009. Role of antibiotic lock therapy for the treatment of catheter-related bloodstream infections. Int. J. Artif. Organs 32:678-688.
6. Dychdala GR. 2001. Chlorine and chlorine compounds, p 135-158. In Block SS (ed), Disinfection, sterilization and preservation. Lippincott Williams & Wilkins, Philadelphia, PA.
7. Giese T, et al. 2004. Differential effects on innate versus adaptive immune responses by WF10. Cell. Immunol. 229:149-158. (Pubitemid 39330222)
8. Gottardi W, Nagl M. 2002. Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system. Arch. Pharm. (Weinheim) 335:411-421. (Pubitemid 35440043)
9. Gottardi W, Nagl M. 2010. N-Chlorotaurine, a natural antiseptic with outstanding tolerability. J. Antimicrob. Chemother. 65:399-409.
10. Henriques ES, Fonseca N, Ramos MJ. 2004. On the modeling of snake venom serine proteinase interactions with benzamidine-based thrombin inhibitors. Protein Sci. 13:2355-2369. (Pubitemid 39136223)
11. Iovino SM, et al. 2011. NVC-422 topical gel for the treatment of impetigo. Int. J. Clin. Exp. Pathol. 4:587-595.
12. Kulawik D. 2010. Antimicrobial lock solutions: an approach to reduce catheter-related bacteremia. Nephrol. Nurs. J. 37:553-555.
13. Low E, et al. 2009. N,N-Dichloroaminosulfonic acids as novel topical antimicrobial agents. Bioorg. Med. Chem. Lett. 19:196-198.
14. Mitchell MD, Anderson BJ, Williams K, Umscheid CA. 2009. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. J. Adv. Nurs. 65:2007-2021.
15. Murina MA, Fesenko OD, Sergienko VI, Chudina NA, Roshchupkin DI. 2002. Antithrombotic activity of N,N-dichlorotaurine on mouse model of thrombosis in vivo. Bull. Exp. Biol. Med. 134:36-38. (Pubitemid 36096905)
16. Murina MA, Roshchupkin DI, Chudina NA, Petrova AO, Sergienko VI. 2009. Antiaggregant effect of taurine chloramines in the presence of serum albumin. Bull. Exp. Biol. Med. 147:704-707.
17. Nagl M, Nguyen VA, Gottardi W, Ulmer H, Höpfl R. 2003. Tolerability and efficacy of N-chlorotaurine compared to chloramine T for treatment of chronic leg ulcers with purulent coating. Br. J. Dermatol. 149:590-597. (Pubitemid 37281593)
18. Neher A, et al. 2004. Acute otitis externa: efficacy and tolerability of N-chlorotaurine, a novel endogenous antiseptic agent. Laryngoscope 114: 850-854. (Pubitemid 38625535)
19. Rosenthal VD, et al. 2010. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am. J. Infect. Control 38:95-104.
20. Steczko J, Ash SR, Nivens DE, Brewer L, Winger RK. 2009. Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens). Nephrol. Dial. Transplant. 24:1937-1945.
21. Stief TW. 2007. Singlet oxygen potentiates thrombolysis. Clin. Appl. Thromb. Hemost. 13:259-278. (Pubitemid 47000550)
22. Stief TW, Aab A, Heimburger N. 1988. Oxidative inactivation of purified human alpha-2-antiplasmin, antithrombin III, and C1-inhibitor. Thromb. Res. 49:581-589.
23. Stief TW, Kurz J, Doss MO, Fareed J. 2000. Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human blood. Thromb. Res. 97:473-480. (Pubitemid 30125714)
24. Teuchner B, et al. 2005. Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis-a double-blind randomized phase 2 clinical trial. J. Ocular Pharmacol. Ther. 21:157-165. (Pubitemid 40577971)
25. Veerasarn V, Boonnuch W, Kakanaporn C. 2006. A phase II study to evaluate WF10 in patients with late hemorrhagic radiation cystitis and proctitis. Gynecol. Oncol. 100:179 -184.
26. Wang L, et al. 2011. Chemical characterization and biological properties of NVC-422, a novel, stable N-chlorotaurine analog. Antimicrob. Agents Chemother. 55:2688-2692.
27. Wang L, Khosrovi B, Najafi R. 2008. N-Chloro-2,2-dimethyltaurines: a new class of remarkably stable N-chlorotaurines. Tetrahedron Lett. 49: 2193-2195.
28. Weber DJ, Rutala WA. 2011. Central line-associated bloodstream infections: prevention and management. Infect. Dis. Clin. North Am. 25:77-102.